Iradimed Co (IRMD) — Capital Reinvestment Ratio
Latest as of March 2026:
0.05x
Iradimed Co (IRMD) has a Capital Reinvestment Ratio of 0.05x as of March 2026, meaning it reinvests 0% of its operating cash flow ($8.29 Million) in capital expenditures ($403.00K). See IRMD FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$8.29 Million
USD
Capital Expenditures
$403.00K
USD
Data as of
Mar 2026
Most recent filing
Iradimed Co Capital Reinvestment Ratio (2012–2025)
This chart tracks Iradimed Co's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Iradimed Co (2012–2025)
Year-by-year Capital Reinvestment Ratio for Iradimed Co from 2012 to 2025. For live market cap and broader valuation context, see how much is Iradimed Co worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | $24.95 Million | $7.76 Million | ▼ -0.4% |
| 2024 | 0.31x | $25.62 Million | $8.01 Million | ▼ -47.5% |
| 2023 | 0.59x | $13.47 Million | $8.01 Million | ▲ +218.5% |
| 2022 | 0.19x | $10.04 Million | $1.87 Million | ▲ +183.4% |
| 2021 | 0.07x | $11.26 Million | $741.76K | ▼ -39.8% |
| 2020 | 0.11x | $5.82 Million | $636.75K | ▲ +130.5% |
| 2019 | 0.05x | $10.23 Million | $485.81K | ▲ +32.3% |
| 2018 | 0.04x | $7.38 Million | $264.67K | ▼ -85.1% |
| 2017 | 0.24x | $3.42 Million | $824.76K | ▲ +49.0% |
| 2016 | 0.16x | $9.41 Million | $1.52 Million | ▲ +293.7% |
| 2015 | 0.04x | $7.65 Million | $314.84K | ▼ -82.4% |
| 2014 | 0.23x | $2.59 Million | $606.29K | ▲ +80.3% |
| 2013 | 0.13x | $1.47 Million | $191.76K | ▲ +21.5% |
| 2012 | 0.11x | $1.51 Million | $161.56K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow